Lipid-Lowering Drugs: Statins and Miscellaneous Agents
The Blood-brain Barrier
Pharmacodynamics: Overview and Principles
Ischemic Stroke ll: Pathophysiology
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Neurochemical Transmission: Sites of Drug Action
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 3, 2026

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
Published on: July 31, 2017
W Gibson Wood1, Walter E Mΰller, Gunter P Eckert
1Geriatric Research, Education and Clinical Center, VAMC, Department of Pharmacology, University of Minnesota School of Medicine, Jackson Hall 6-120, 321 Church St, Minneapolis, MN, 55455, USA, woodx002@umn.edu.
Statins show promise for neurodegenerative diseases like Alzheimer's and Parkinson's. Further research into statin pharmacokinetics and pharmacodynamics in the brain is needed to optimize their use.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: